BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37632668)

  • 1. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
    J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study.
    Stefan G; Stancu S; Zugravu A; Terinte-Balcan G
    Ren Fail; 2024 Dec; 46(1):2313179. PubMed ID: 38357771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
    Puapatanakul P; Banjongjit A; Kanjanabuch T; Surintrspanont J; Iampenkhae K; Praditpornsilpa K; Eiam-Ong S; Boonpucknavig V
    Am J Nephrol; 2023; 54(7-8):308-318. PubMed ID: 37429271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Mesangial C4d Staining in IgA Nephropathy: A Tunisian Study.
    Jebali H; Ghabi H; Mami I; Fatma LB; Haouet S; Mahjouba HB; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2021; 32(3):691-698. PubMed ID: 35102910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
    Trimarchi H; Coppo R
    Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
    Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
    Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
    Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
    Bobart SA; Alexander MP; Shawwa K; Vaughan LE; Ghamrawi R; Sethi S; Cornell L; Glassock RJ; Fervenza FC; Zand L
    Nephrol Dial Transplant; 2021 Apr; 36(5):840-847. PubMed ID: 31859353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.